GordonMD® Global Investments LP is a financial services firm specializing in investment management within the biopharmaceutical sector. The company was founded in 2021 by Craig Gordon, a licensed physician with extensive experience in managing global biopharmaceutical portfolios. The firm operates private and public funds, focusing on investment opportunities in biopharmaceutical companies primarily in the U.S., Europe, and Japan. Their investment approach leverages Dr. Gordon's medical practice background, bottom-up analysis, and industry contacts to identify growth opportunities that may be overlooked by the broader market.

GordonMD® Global Investments LP

Gordon MD Global Investments was founded in 2021 by Craig Gordon, MD, a licensed physician with 10+ years of buy-side experience managing global biopharmaceutical portfolios.

The firm manages a private fund and a public fund, each focused on differentiated investment opportunities in biopharmaceutical companies primarily located in the U.S., Europe and Japan.

Metric
Company Name	GordonMD® Global Investments LP
Symbol
MSH ID	COM:GORDONMDGLOBALINVESTMENT
Market	PRIVATE
Sector	Financial Services & Finance
Industry	Investment Management
Country	US
Stage
Employee Count	8
Website	gordonmdglobalinvestment.com
LinkedIn	gordonmd-global-investments-lp
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:GORDONMDGLOBALINVESTMENT

GordonMD® Global Investments LP

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue